Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Bar-Or

Showing results (61-70 of 409) with videos related to

Pageof 41
Sort By:
Drugs|April 18, 2014
Teriflunomide and its mechanism of action in multiple sclerosisAmit Bar-Or, Andrew Pachner, Francoise Menguy-Vacheron, et al.
The Lancet. Neurology|March 22, 2025
Multiple sclerosis and COVID-19: interactions and unresolved issuesAna Zabalza, Alan Thompson, Dalia L Rotstein, et al.
Archives of Neurology|January 14, 2009
Defining multiple sclerosis treatment response with magnetic resonance imaging: how much activity is too much?Paul S Giacomini, Douglas L Arnold, Amit Bar-Or, et al.
Nature Reviews. Neurology|October 26, 2019
Immune reconstitution therapies: concepts for durable remission in multiple sclerosisJan D Lünemann, Tobias Ruck, Paolo A Muraro, et al.
Clinical Immunology (Orlando, Fla.)|April 20, 2004
Inflammatory potential and migratory capacities across human brain endothelial cells of distinct glatiramer acetate-reactive T cells generated in treated multiple sclerosis patientsHo Jin Kim, Katarzyna Biernacki, Alexandre Prat, et al.
Nature Reviews. Neurology|June 2, 2021
B cells in multiple sclerosis - from targeted depletion to immune reconstitution therapiesMaria T Cencioni, Miriam Mattoscio, Roberta Magliozzi, et al.
Nature Reviews. Neurology|January 16, 2020
Author Correction: Immune reconstitution therapies: concepts for durable remission in multiple sclerosisJan D Lünemann, Tobias Ruck, Paolo A Muraro, et al.
Neurology|October 18, 2013
Basis for fluctuations in lymphocyte counts in fingolimod-treated patients with multiple sclerosisDavid Henault, Lorna Galleguillos, Craig Moore, et al.
The Lancet. Neurology|August 22, 2014
Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and researchAmy Waldman, Angelo Ghezzi, Amit Bar-Or, et al.
Current Opinion in Neurology|June 8, 2022
Multiple sclerosis in the era of COVID-19: disease course, DMTs and SARS-CoV2 vaccinationsMaura Pugliatti, Thomas Berger, Hans-Peter Hartung, et al.
Pageof 41

Showing results (61-70 of 409) with videos related to

Sort By:
Pageof 41
Drugs|April 18, 2014
Teriflunomide and its mechanism of action in multiple sclerosisAmit Bar-Or, Andrew Pachner, Francoise Menguy-Vacheron, et al.
The Lancet. Neurology|March 22, 2025
Multiple sclerosis and COVID-19: interactions and unresolved issuesAna Zabalza, Alan Thompson, Dalia L Rotstein, et al.
Archives of Neurology|January 14, 2009
Defining multiple sclerosis treatment response with magnetic resonance imaging: how much activity is too much?Paul S Giacomini, Douglas L Arnold, Amit Bar-Or, et al.
Nature Reviews. Neurology|October 26, 2019
Immune reconstitution therapies: concepts for durable remission in multiple sclerosisJan D Lünemann, Tobias Ruck, Paolo A Muraro, et al.
Clinical Immunology (Orlando, Fla.)|April 20, 2004
Inflammatory potential and migratory capacities across human brain endothelial cells of distinct glatiramer acetate-reactive T cells generated in treated multiple sclerosis patientsHo Jin Kim, Katarzyna Biernacki, Alexandre Prat, et al.
Nature Reviews. Neurology|June 2, 2021
B cells in multiple sclerosis - from targeted depletion to immune reconstitution therapiesMaria T Cencioni, Miriam Mattoscio, Roberta Magliozzi, et al.
Nature Reviews. Neurology|January 16, 2020
Author Correction: Immune reconstitution therapies: concepts for durable remission in multiple sclerosisJan D Lünemann, Tobias Ruck, Paolo A Muraro, et al.
Neurology|October 18, 2013
Basis for fluctuations in lymphocyte counts in fingolimod-treated patients with multiple sclerosisDavid Henault, Lorna Galleguillos, Craig Moore, et al.
The Lancet. Neurology|August 22, 2014
Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and researchAmy Waldman, Angelo Ghezzi, Amit Bar-Or, et al.
Current Opinion in Neurology|June 8, 2022
Multiple sclerosis in the era of COVID-19: disease course, DMTs and SARS-CoV2 vaccinationsMaura Pugliatti, Thomas Berger, Hans-Peter Hartung, et al.
Pageof 41